302 related articles for article (PubMed ID: 12891312)
1. [Effect of drug therapy on frequency of adequate discharges of implanted cardioverter defibrillator].
Tiroke A; Ganeeva ON
Kardiologiia; 2003; 43(6):54-8. PubMed ID: 12891312
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of appropriate cardioverter-defibrillator shocks in 1038 consecutive patients with implantable cardioverter-defibrillators.
Kruger A; Aronow WS; Lai H; Desai H; Singla A; Frishman WH; Cohen M; Sorbera C
Am J Ther; 2009; 16(4):323-5. PubMed ID: 19617719
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
Bollmann A; Husser D; Cannom DS
Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
[TBL] [Abstract][Full Text] [Related]
4. [Implantable cardioverter defibrillator does not eliminate need for antiarrhythmic drugs in secondary prevention of life threatening ventricular arrhythmias. Results of OPTIC trial].
Iavelov IS
Kardiologiia; 2006; 46(3):74-5. PubMed ID: 16710262
[No Abstract] [Full Text] [Related]
5. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Hohnloser SH; Dorian P; Roberts R; Gent M; Israel CW; Fain E; Champagne J; Connolly SJ
Circulation; 2006 Jul; 114(2):104-9. PubMed ID: 16818810
[TBL] [Abstract][Full Text] [Related]
6. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
Ho AT; Pai SM; Timothy P; Pai RG
Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
[TBL] [Abstract][Full Text] [Related]
7. Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia.
Pokorney SD; Mi X; Hammill BG; Allen LaPointe NM; Curtis LH; Al-Khatib SM
Am J Cardiol; 2017 May; 119(9):1401-1406. PubMed ID: 28341360
[TBL] [Abstract][Full Text] [Related]
8. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
9. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.
Connolly SJ; Dorian P; Roberts RS; Gent M; Bailin S; Fain ES; Thorpe K; Champagne J; Talajic M; Coutu B; Gronefeld GC; Hohnloser SH;
JAMA; 2006 Jan; 295(2):165-71. PubMed ID: 16403928
[TBL] [Abstract][Full Text] [Related]
10. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
[TBL] [Abstract][Full Text] [Related]
11. Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy.
Droogan C; Patel C; Yan GX; Kowey PR
Heart Fail Clin; 2011 Apr; 7(2):195-205, viii. PubMed ID: 21439498
[TBL] [Abstract][Full Text] [Related]
12. Interactions between implantable cardioverter-defibrillators and class III agents.
Movsowitz C; Marchlinski FE
Am J Cardiol; 1998 Aug; 82(4A):41I-48I. PubMed ID: 9737653
[TBL] [Abstract][Full Text] [Related]
13. Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy.
Steinbeck G; Greene HL
Prog Cardiovasc Dis; 1996; 38(6):419-28. PubMed ID: 8638023
[TBL] [Abstract][Full Text] [Related]
14. Sotalol in patients with implanted automatic defibrillators: effects on defibrillation and comparison with amiodarone.
Dorian P; Newman D; Harris L; Downar E
Can J Cardiol; 1994 Mar; 10(2):193-200. PubMed ID: 8143220
[TBL] [Abstract][Full Text] [Related]
15. Implantable defibrillators and/or amiodarone: alternatives or complementary therapies.
Dorian P; Newman D; Greene M
Int J Clin Pract; 1998 Sep; 52(6):425-8. PubMed ID: 9894382
[TBL] [Abstract][Full Text] [Related]
16. Role of amiodarone in the era of the implantable cardioverter defibrillator.
Dorian P; Mangat I
J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S78-81. PubMed ID: 12950525
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive therapy for recurrent ventricular tachycardia in patients with implantable cardioverter defibrillators.
Reiffel JA
Curr Cardiol Rep; 2007 Sep; 9(5):381-6. PubMed ID: 17877933
[TBL] [Abstract][Full Text] [Related]
18. A comparison of long-standing implantable cardioverter-defibrillator patients with and without appropriate therapy for ventricular arrhythmias: impact of a widening QRS.
Dizon J; Chen K; Dizon S; Biviano A; Whang W; Ehlert F; Vazquez J; Nazif T; Garan H
Europace; 2011 Jan; 13(1):77-81. PubMed ID: 21149513
[TBL] [Abstract][Full Text] [Related]
19. Controlling cardiac arrhythmias: an overview with a historical perspective.
Singh BN
Am J Cardiol; 1997 Oct; 80(8A):4G-15G. PubMed ID: 9354407
[TBL] [Abstract][Full Text] [Related]
20. Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
Mitchell LB
J Am Coll Cardiol; 2009 Aug; 54(7):616-7. PubMed ID: 19660691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
